Copyright Reports & Markets. All rights reserved.

Global Liposomes Drug Delivery Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Liposomes Drug Delivery Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Liposomal Doxorubicin
    • 1.3.3 Liposomal Amphoteracin B
    • 1.3.4 Liposomal Paclitaxel
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Liposomes Drug Delivery Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Fungal Infection Therapy
    • 1.4.3 Cancer & Tumor Therapy
    • 1.4.4 Others
  • 1.5 Global Liposomes Drug Delivery Market Size & Forecast
    • 1.5.1 Global Liposomes Drug Delivery Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Liposomes Drug Delivery Sales Quantity (2021-2032)
    • 1.5.3 Global Liposomes Drug Delivery Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Liposomes Drug Delivery Product and Services
    • 2.1.4 Johnson & Johnson Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Johnson & Johnson Recent Developments/Updates
  • 2.2 Gilead Sciences
    • 2.2.1 Gilead Sciences Details
    • 2.2.2 Gilead Sciences Major Business
    • 2.2.3 Gilead Sciences Liposomes Drug Delivery Product and Services
    • 2.2.4 Gilead Sciences Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Gilead Sciences Recent Developments/Updates
  • 2.3 Pacira
    • 2.3.1 Pacira Details
    • 2.3.2 Pacira Major Business
    • 2.3.3 Pacira Liposomes Drug Delivery Product and Services
    • 2.3.4 Pacira Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Pacira Recent Developments/Updates
  • 2.4 Sun Pharmaceutical
    • 2.4.1 Sun Pharmaceutical Details
    • 2.4.2 Sun Pharmaceutical Major Business
    • 2.4.3 Sun Pharmaceutical Liposomes Drug Delivery Product and Services
    • 2.4.4 Sun Pharmaceutical Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sun Pharmaceutical Recent Developments/Updates
  • 2.5 Luye Pharma
    • 2.5.1 Luye Pharma Details
    • 2.5.2 Luye Pharma Major Business
    • 2.5.3 Luye Pharma Liposomes Drug Delivery Product and Services
    • 2.5.4 Luye Pharma Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Luye Pharma Recent Developments/Updates
  • 2.6 Sigma-Tau Group
    • 2.6.1 Sigma-Tau Group Details
    • 2.6.2 Sigma-Tau Group Major Business
    • 2.6.3 Sigma-Tau Group Liposomes Drug Delivery Product and Services
    • 2.6.4 Sigma-Tau Group Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sigma-Tau Group Recent Developments/Updates
  • 2.7 Fudan-Zhangjiang
    • 2.7.1 Fudan-Zhangjiang Details
    • 2.7.2 Fudan-Zhangjiang Major Business
    • 2.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Product and Services
    • 2.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Fudan-Zhangjiang Recent Developments/Updates
  • 2.8 Teva Pharmaceutical
    • 2.8.1 Teva Pharmaceutical Details
    • 2.8.2 Teva Pharmaceutical Major Business
    • 2.8.3 Teva Pharmaceutical Liposomes Drug Delivery Product and Services
    • 2.8.4 Teva Pharmaceutical Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.9 CSPC
    • 2.9.1 CSPC Details
    • 2.9.2 CSPC Major Business
    • 2.9.3 CSPC Liposomes Drug Delivery Product and Services
    • 2.9.4 CSPC Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CSPC Recent Developments/Updates
  • 2.10 Novartis
    • 2.10.1 Novartis Details
    • 2.10.2 Novartis Major Business
    • 2.10.3 Novartis Liposomes Drug Delivery Product and Services
    • 2.10.4 Novartis Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Novartis Recent Developments/Updates
  • 2.11 Kingond Pharm
    • 2.11.1 Kingond Pharm Details
    • 2.11.2 Kingond Pharm Major Business
    • 2.11.3 Kingond Pharm Liposomes Drug Delivery Product and Services
    • 2.11.4 Kingond Pharm Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Kingond Pharm Recent Developments/Updates
  • 2.12 Spectrum Pharmaceuticals
    • 2.12.1 Spectrum Pharmaceuticals Details
    • 2.12.2 Spectrum Pharmaceuticals Major Business
    • 2.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Product and Services
    • 2.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Spectrum Pharmaceuticals Recent Developments/Updates
  • 2.13 Shanghai New Asia
    • 2.13.1 Shanghai New Asia Details
    • 2.13.2 Shanghai New Asia Major Business
    • 2.13.3 Shanghai New Asia Liposomes Drug Delivery Product and Services
    • 2.13.4 Shanghai New Asia Liposomes Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Shanghai New Asia Recent Developments/Updates

3 Competitive Environment: Liposomes Drug Delivery by Manufacturer

  • 3.1 Global Liposomes Drug Delivery Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Liposomes Drug Delivery Revenue by Manufacturer (2021-2026)
  • 3.3 Global Liposomes Drug Delivery Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Liposomes Drug Delivery by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Liposomes Drug Delivery Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Liposomes Drug Delivery Manufacturer Market Share in 2025
  • 3.5 Liposomes Drug Delivery Market: Overall Company Footprint Analysis
    • 3.5.1 Liposomes Drug Delivery Market: Region Footprint
    • 3.5.2 Liposomes Drug Delivery Market: Company Product Type Footprint
    • 3.5.3 Liposomes Drug Delivery Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Liposomes Drug Delivery Market Size by Region
    • 4.1.1 Global Liposomes Drug Delivery Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Liposomes Drug Delivery Consumption Value by Region (2021-2032)
    • 4.1.3 Global Liposomes Drug Delivery Average Price by Region (2021-2032)
  • 4.2 North America Liposomes Drug Delivery Consumption Value (2021-2032)
  • 4.3 Europe Liposomes Drug Delivery Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Liposomes Drug Delivery Consumption Value (2021-2032)
  • 4.5 South America Liposomes Drug Delivery Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Liposomes Drug Delivery Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Liposomes Drug Delivery Sales Quantity by Type (2021-2032)
  • 5.2 Global Liposomes Drug Delivery Consumption Value by Type (2021-2032)
  • 5.3 Global Liposomes Drug Delivery Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Liposomes Drug Delivery Sales Quantity by Application (2021-2032)
  • 6.2 Global Liposomes Drug Delivery Consumption Value by Application (2021-2032)
  • 6.3 Global Liposomes Drug Delivery Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Liposomes Drug Delivery Sales Quantity by Type (2021-2032)
  • 7.2 North America Liposomes Drug Delivery Sales Quantity by Application (2021-2032)
  • 7.3 North America Liposomes Drug Delivery Market Size by Country
    • 7.3.1 North America Liposomes Drug Delivery Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Liposomes Drug Delivery Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Liposomes Drug Delivery Sales Quantity by Type (2021-2032)
  • 8.2 Europe Liposomes Drug Delivery Sales Quantity by Application (2021-2032)
  • 8.3 Europe Liposomes Drug Delivery Market Size by Country
    • 8.3.1 Europe Liposomes Drug Delivery Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Liposomes Drug Delivery Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Liposomes Drug Delivery Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Liposomes Drug Delivery Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Liposomes Drug Delivery Market Size by Region
    • 9.3.1 Asia-Pacific Liposomes Drug Delivery Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Liposomes Drug Delivery Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Liposomes Drug Delivery Sales Quantity by Type (2021-2032)
  • 10.2 South America Liposomes Drug Delivery Sales Quantity by Application (2021-2032)
  • 10.3 South America Liposomes Drug Delivery Market Size by Country
    • 10.3.1 South America Liposomes Drug Delivery Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Liposomes Drug Delivery Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Liposomes Drug Delivery Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Liposomes Drug Delivery Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Liposomes Drug Delivery Market Size by Country
    • 11.3.1 Middle East & Africa Liposomes Drug Delivery Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Liposomes Drug Delivery Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Liposomes Drug Delivery Market Drivers
  • 12.2 Liposomes Drug Delivery Market Restraints
  • 12.3 Liposomes Drug Delivery Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Liposomes Drug Delivery and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Liposomes Drug Delivery
  • 13.3 Liposomes Drug Delivery Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Liposomes Drug Delivery Typical Distributors
  • 14.3 Liposomes Drug Delivery Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Liposomes Drug Delivery market size was valued at US$ 4520 million in 2025 and is forecast to a readjusted size of US$ 8616 million by 2032 with a CAGR of 9.8% during review period.
    Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
    In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
    North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
    Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
    This report is a detailed and comprehensive analysis for global Liposomes Drug Delivery market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Liposomes Drug Delivery market size and forecasts, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2021-2032
    Global Liposomes Drug Delivery market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2021-2032
    Global Liposomes Drug Delivery market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2021-2032
    Global Liposomes Drug Delivery market shares of main players, shipments in revenue ($ Million), sales quantity (K Vials), and ASP (USD/Vial), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Liposomes Drug Delivery
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Liposomes Drug Delivery market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical, CSPC, Novartis, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Liposomes Drug Delivery market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Liposomal Doxorubicin
    Liposomal Amphoteracin B
    Liposomal Paclitaxel
    Others
    Market segment by Application
    Fungal Infection Therapy
    Cancer & Tumor Therapy
    Others
    Major players covered
    Johnson & Johnson
    Gilead Sciences
    Pacira
    Sun Pharmaceutical
    Luye Pharma
    Sigma-Tau Group
    Fudan-Zhangjiang
    Teva Pharmaceutical
    CSPC
    Novartis
    Kingond Pharm
    Spectrum Pharmaceuticals
    Shanghai New Asia
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Liposomes Drug Delivery product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Liposomes Drug Delivery, with price, sales quantity, revenue, and global market share of Liposomes Drug Delivery from 2021 to 2026.
    Chapter 3, the Liposomes Drug Delivery competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Liposomes Drug Delivery breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Liposomes Drug Delivery market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Liposomes Drug Delivery.
    Chapter 14 and 15, to describe Liposomes Drug Delivery sales channel, distributors, customers, research findings and conclusion.

    Buy now